All In MedTech

Device Trial Radar · NCT07840937

Feasibility Study of E-Fusion Vasopressor Titration-Assist During Multi-Level Spine Surgery

Feasibility Study of E-Fusion Vasopressor Titration-Assist as a Clinical Decision Support Tool During Multi-Level Spine Surgery

Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Mar 2027

Primary completion

Aug 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Autonomous Healthcare, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Sep 25, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a single-arm feasibility study of E-Fusion Vasopressor Titration-Assist, a clinical decision support software, in 10 adults undergoing multi-level spine surgery. E-Fusion monitors blood pressure from the patient monitor and displays recommended changes to the norepinephrine infusion rate. The anesthesia provider independently reviews each recommendation and may accept or ignore it. The software does not connect to or control the infusion pump. The primary objective is to assess safety by evaluating adverse events attributable to E-Fusion during surgery. Secondary objectives evaluate clinician agreement with the recommendations and blood pressure management.

Conditions

  • Intraoperative Hypotension

Interventions

  • E-Fusion Vasopressor Titration-AssistDevice

    Clinical decision support software that monitors mean arterial pressure from the patient monitor and displays recommended norepinephrine infusion rate changes. The clinician independently evaluates each recommendation and makes all infusion rate changes manually. The software does not connect to or control the infusion pump.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of adverse events and serious adverse events of relevance attributed to E-FusionTime frame: Intraoperative period, from E-Fusion activation to deactivation or end of surgery, up to 8 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.